BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4588532)

  • 1. [Clinical demonstration of the action of liver drugs].
    Einsiedel-Schömer W
    Z Allgemeinmed; 1973 Oct; 49(30):1452-5. PubMed ID: 4588532
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results of the short-term treatment of active chronic liver diseases with betamethasone].
    Sarti F; Milandri GL; Giuliani Piccari G; Formica G; Spongano P; Accardo P
    G Clin Med; 1982 Jun; 63(6):392-400. PubMed ID: 6816654
    [No Abstract]   [Full Text] [Related]  

  • 3. From chemical to drug: neurodegeneration drug screening and the ethics of clinical trials.
    Heemskerk J; Tobin AJ; Ravina B
    Nat Neurosci; 2002 Nov; 5 Suppl():1027-9. PubMed ID: 12403977
    [No Abstract]   [Full Text] [Related]  

  • 4. The development of cianidanol and 3-palmitoyl-(+)-catechin as drugs for the treatment of liver diseases.
    Perrissoud D
    Prog Clin Biol Res; 1986; 213():559-69. PubMed ID: 3520595
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic action of arginine-thiazolidine-carboxylate (ATCA) as evaluated by liver function tests].
    Alvisĭ V; D'Ambrosi A; Lo Ponte A; Tampieri ML; Tralli M
    Arch Sci Med (Torino); 1980; 137(4):731-8. PubMed ID: 7018458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial: A shortage of reliable data.
    Chalmers TC
    N Engl J Med; 1976 Mar; 294(13):721-22. PubMed ID: 765823
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pathophysiologic, pathomorphologic and clinical principles of a rational liver therapy].
    Franken FH
    Hippokrates; 1971 Mar; 42(1):25-39. PubMed ID: 5550582
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of liver damage during a course of tuberculosis and chronic pulmonary diseases. Necessity of treatment and new trends].
    Mariani B; Marchioni GF; Capitolo S
    Minerva Med; 1974 Aug; 65(57):2977-89. PubMed ID: 4603931
    [No Abstract]   [Full Text] [Related]  

  • 9. [The therapy of chronic liver diseases].
    Franken FH
    Dtsch Med Wochenschr; 1968 Jan; 93(3):129-33. PubMed ID: 5637980
    [No Abstract]   [Full Text] [Related]  

  • 10. Laboratory assessment of severe chronic active liver disease during and after corticosteroid therapy: correlation of serum transaminase and gamma globulin levels with histologic features.
    Czaja AJ; Wolf AM; Baggenstoss AH
    Gastroenterology; 1981 Apr; 80(4):687-92. PubMed ID: 6162704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Morphologic evaluation of the effectiveness of hepatic drugs].
    Záhor Z
    Cas Lek Cesk; 1988 Oct; 127(43):1329-33. PubMed ID: 3208276
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hepatology at the turn of centuries].
    Nogaller AM
    Klin Med (Mosk); 2002; 80(9):13-7. PubMed ID: 12416218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antioxidants in experimental and clinical hepatology].
    Khvorostinka VN; Moiseenko TA
    Vrach Delo; 1991 Jul; (7):17-22. PubMed ID: 1771826
    [No Abstract]   [Full Text] [Related]  

  • 14. ["Essential" phospholipids in hepatology (experimental and clinical tests)].
    Kuntz E; Gundermann KJ; Schneider E
    Ter Arkh; 1994; 66(2):66-72. PubMed ID: 8160152
    [No Abstract]   [Full Text] [Related]  

  • 15. Translation: case study in failure.
    Johnston SC
    Ann Neurol; 2006 Mar; 59(3):447-8. PubMed ID: 16489618
    [No Abstract]   [Full Text] [Related]  

  • 16. A controlled clinical trial of lactulose in hepatic encephalopathy.
    Simmons F; Goldstein H; Boyle JD
    Gastroenterology; 1970 Dec; 59(6):827-32. PubMed ID: 4922276
    [No Abstract]   [Full Text] [Related]  

  • 17. Beneficial drugs for liver diseases.
    Muriel P; Rivera-Espinoza Y
    J Appl Toxicol; 2008 Mar; 28(2):93-103. PubMed ID: 17966118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of chronic liver diseases].
    Hilt G; Reitmeier H
    Z Allgemeinmed; 1973 Mar; 49(7):327-9. PubMed ID: 4593070
    [No Abstract]   [Full Text] [Related]  

  • 19. [Values and limitations of an epidemiological survey for the detection of chronic liver diseases].
    Dusi U; Avogaro P; Crepaldi G; Enzi G
    Minerva Med; 1968 Feb; 59(10):504-14. PubMed ID: 5642233
    [No Abstract]   [Full Text] [Related]  

  • 20. [Three patients with weight loss as a result of sarcoidosis presenting as liver disease].
    Hoefnagels MA; van Leusen R; de Vries RA
    Ned Tijdschr Geneeskd; 2003 Dec; 147(50):2453-7. PubMed ID: 14708207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.